IPP Bureau
FDA approves Alembic’s Triamcinolone Acetonide injectable suspension USP, 40 mg/mL
By IPP Bureau - October 19, 2025
Triamcinolone Acetonide injectable suspension USP is indicated for various autoimmune, inflammatory, and other conditions
Cupid achieves CE (EU IVDR) certification for pregnancy and syphilis test kits
By IPP Bureau - October 19, 2025
Gujarat Themis Biosyn doubles fermentation production capacity at Vapi
By IPP Bureau - October 19, 2025
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
Strides partners with Incepta to expand women's health access with WHO-prequalified contraceptive
By IPP Bureau - October 18, 2025
Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
Indegene strengthens consulting practice to accelerate life sciences transformation
By IPP Bureau - October 18, 2025
Indegene is strengthening its Consulting Practice to help life sciences organizations address their most pressing challenges with speed, impact, and accountability
IKS Health announces generative AI platform built on Google cloud
By IPP Bureau - October 18, 2025
IKS Health's innovative solution orchestrates a roll out of critical operations functions into a unified and efficient connected workflow
Novelix signs technology transfer agreement with Germany-based GMBU for production of Astaxanthin
By IPP Bureau - October 18, 2025
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Biocon Biologics and Civica launch private-label Insulin glargine
By IPP Bureau - October 18, 2025
Novo Nordisk acquires Omeros’ MASP-3 inhibitor Zaltenibart for up to US$ 340 million
By IPP Bureau - October 17, 2025
Zaltenibart offers best-in-class potential across multiple rare blood and kidney disorders, enhancing Novo Nordisk’s rare disease portfolio
Pfizer’s TUKYSA boosts front-line outcomes, extending progression-free survival in HER2+ metastatic breast cancer
By IPP Bureau - October 17, 2025
Treatment with TUKYSA was well-tolerated, with a safety profile consistent with previously known profiles of the individual agents
Healthium partners with US-based Tisgenx to bring cardiac innovations to India
By IPP Bureau - October 17, 2025
This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment
Aragen appoints Neeraj Garg as CEO - Discovery Solutions business
By IPP Bureau - October 16, 2025
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
AstraZeneca Pharma India to launch Sodium Zirconium Cyclosilicate powder in Nov 2025
By IPP Bureau - October 16, 2025
Sodium Zirconium Cyclosilicate powder for oral suspension 5g (Lokelma) is indicated for the treatment of hyperkalaemia in adult patients
IOL Chemicals receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III
By IPP Bureau - October 16, 2025
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
